Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
Baldamus
C A
CA
Department of Internal Medicine I, University of Cologne, FRG.
Steffen
A M
AM
Brunner
R
R
Pollok
M
M
D000740:Anemia / Q000150:complications* / Q000209:etiology / Q000628:therapy; D001794:Blood Pressure / Q000502:physiology; D001809:Blood Viscosity / Q000502:physiology*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
D011994:Recombinant Proteins; D004921:Erythropoietin